Adopting a minimally invasive approach and implementing evidence-based management protocols can preserve tooth structure and improve outcomes.

The U.S. Food and Drug Administration (FDA) has granted its breakthrough therapy designation to silver diamine fluoride 38% (Advantage Arrest, Elevate Oral Care) for use in arresting dental caries in children and adults.